Comparison of BAC and Oligo Array CGH in Prostate Cancer
Author Information
Author(s): Wicker Nicolas, Carles Annaïck, Mills Ian G, Wolf Maija, Veerakumarasivam Abhi, Edgren Henrik, Boileau Fabrice, Wasylyk Bohdan, Schalken Jack A, Neal David E, Kallioniemi Olli, Poch Olivier
Primary Institution: Institut de Génétique et de Biologie Moléculaire et Cellulaire
Hypothesis
The study aims to statistically compare the correlation and discriminative power of BAC-based and oligonucleotide-based array CGH platforms using human patient samples.
Conclusion
The oligo array platform is statistically superior to the BAC platform for identifying chromosomal events in prostate cancer samples.
Supporting Evidence
- The study found a significant correlation between BAC and oligo platforms when analyzing raw data.
- Segmentation improved the correlation between the two platforms.
- The oligo platform detected more deletions and amplifications compared to the BAC platform.
- A statistical model was developed to identify BAC outliers that may indicate microevents.
- 14% of BAC segments were found to be divergent from oligo segments.
Takeaway
This study looked at two different ways to check for DNA changes in cancer and found that one method is better at spotting smaller changes.
Methodology
The study compared BAC and oligo array CGH platforms using raw data from 19 advanced prostate cancer samples, applying statistical models and segmentation algorithms.
Limitations
The study's findings may not be generalizable beyond advanced prostate cancer due to the specific patient sample used.
Participant Demographics
The sample consisted of 19 advanced prostate cancer samples from 18 patients.
Statistical Information
P-Value
1e-15
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website